Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200525047563N1Phase 3Completed
Phase 3, open-label trial of morphine (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Urinary retention and Complaint of incomplete urination. Started May 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200525047563N1.